SCHEMBL22562929

SCHEMBL22562929

COCCOCCn1cc(SNC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC5(CCC5)CC4)CC3)cc2Oc2cnc3[nH]ccc3c2)cc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20793853 0.90 BCL2 (0.76) BCL2
SCHEMBL22562899 0.89 BCL2 (0.69) BCL2
SCHEMBL24982718 0.89 BCL2 (0.69) BCL2
SCHEMBL23865967 0.88 BCL2 (0.72) BCL2
SCHEMBL20580667 0.87 BCL2 (0.78) BCL2
SCHEMBL29373371 0.87 BCL2 (0.78) BCL2
SCHEMBL24982719 0.87 BCL2 (0.61) BCL2
SCHEMBL24166413 0.85 BCL2 (0.82) BCL2
SCHEMBL19853637 0.85 BCL2 (0.82) BCL2
SCHEMBL23653663 0.84 BCL2 (0.69) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672595-B1 COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES ASCENTAGE PHARMA SUZHOU CO LTD (CN) 2021-07-21 — — EP disclosed
EP-3494115-B1 N-(PHENYLSULFONYL)BENZAMIDE DERIVATIVES AS BCL-2 INHIBITORS UNIV MICHIGAN REGENTS (US) 2020-10-21 — — EP disclosed
Send feedback